SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-013786
Filing Date
2021-10-29
Accepted
2021-10-29 06:43:32
Documents
14
Period of Report
2021-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20211029x8k.htm   iXBRL 8-K 36389
2 EX-99.1 imgn-20211029xex99d1.htm EX-99.1 204094
3 GRAPHIC imgn-20211029xex99d1001.jpg GRAPHIC 150092
  Complete submission text file 0001558370-21-013786.txt   578823

Data Files

Seq Description Document Type Size
4 EX-101.SCH imgn-20211029.xsd EX-101.SCH 2986
5 EX-101.LAB imgn-20211029_lab.xml EX-101.LAB 16755
6 EX-101.PRE imgn-20211029_pre.xml EX-101.PRE 9902
7 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20211029x8k_htm.xml XML 4688
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 211360556
SIC: 2834 Pharmaceutical Preparations